Dye & Durham Reports Second Quarter Fiscal 2026 Financial Results
-
Revenue for the three and six months ended
December 31, 2025 of$107.0 million and$215.3 million , respectively. -
Net loss for the three and six months ended
December 31, 2025 of$(21.8) million and$(60.1) million , respectively. -
Adjusted EBITDA¹ for the three and six ended
December 31, 2025 of$50.4 million and$100.8 million , respectively.
"Our second quarter reflects a business moving from stabilization to consistent execution," says
Second Quarter Fiscal 2026 Highlights ($ presented in thousands)
Consolidated highlights
|
Selected key metrics : |
|
Three months ended |
Six months ended |
||||
|
|
|
|
2024 |
|
2024 |
||
|
|
|
2025 |
(Restated) |
2025 |
(Restated) |
||
|
|
|
$ |
$ |
$ |
$ |
||
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
||
|
Revenue |
|
107,024 |
115,746 |
215,326 |
232,137 |
||
|
|
|
|
|
|
|
||
|
Net loss |
|
|
(21,790) |
(19,664) |
(60,062) |
(34,959) |
|
|
Cash flow from operating activities |
|
33,577 |
15,626 |
73,794 |
62,266 |
||
|
Adjusted EBITDA(1) |
|
50,352 |
64,652 |
100,787 |
132,203 |
||
|
|
|
|
Certain comparative figures for the three and six months ended |
|
|
|
|
|
(1) Represents a non-IFRS measure. See "Non-IFRS Measures." |
- Revenue for the three months ended
December 31, 2025 , was$107.0 million , a decrease of$8.7 million , or 8%, compared to the three months endedDecember 31, 2024 . Revenue for the six months endedDecember 31, 2025 andDecember 31, 2024 was$215.3 million and$232.1 million , respectively, a decrease of$16.8 million , or 7%. The decrease was primarily driven by a combination of market downturn and the impact of lower volumes and pricing from both the loss of customers and contract renewal terms affecting practice management and data insights platforms, partially offset by growth in Banking Technology and Affinity. - Net loss for the three months ended
December 31, 2025 was$21.8 million , compared to a net loss of$19.7 million for the equivalent period in the prior year. Net loss for the six months endedDecember 31, 2025 was$60.1 million , compared to a net loss of$35.0 million for the equivalent period in the prior year. The greater loss was primarily driven by lower revenue, higher operating expenses, and the stock based compensation reversal in the prior periods partially offset by lower interest costs, lower amortization and lower acquisition, restructuring and other costs. - Net cash provided by operating activities for the three months ended
December 31, 2025 was$33.6 million , compared to$15.6 million for the equivalent period in the prior year. The year over year improvement in cash flow from operations was driven by lower financing costs, lower taxes paid, and improvements in working capital. - Adjusted EBITDA(1) for the three months ended
December 31, 2025 was$50.4 million , a decrease of$14.3 million , or 22%, compared to the three months endedDecember 31, 2024 . For the six months endedDecember 31, 2025 and 2024, Adjusted EBITDA(1) was$100.8 million and$132.2 million , respectively, a decrease of$31.4 million , or 24%. The decrease in Adjusted EBITDA(1) was driven by revenue impacts described above, strategic reinvestments necessary to stabilize the business, predominantly labour and IT infrastructure, and a lower capitalization rate as the Company temporarily shifted certain expenditures from capitalized projects to maintenance expense. - The Company was in compliance with the financial maintenance covenant under its senior credit agreement with respect to the three months ended
December 31, 2025 . AtDecember 31, 2025 , the Company had drawn$61.5 million on the revolving credit facility and the Consolidated First Lien Net Leverage Ratio (as such term is defined in the senior credit agreement) was approximately 4.98x.
Quarterly Dividend
As previously disclosed in the Company's press release dated
Conference Call Notification
As previously disclosed, the Company will host a conference call on
C onference Call Details
|
Date: |
|
|
Time: |
|
|
Conference Call: |
Toll Free Dial-In Number: 1-888-699-1199 |
|
|
Dial-In Number (GTA): 416-945-7677 |
|
Webcast URL: |
|
|
|
Please dial in at least five minutes before the call begins. |
|
|
|
|
Replay: |
Available through |
|
Replay Access: |
Toll-Free Dial-In Number: 1-888-660-6345 |
|
|
Dial-In Number (GTA): 646-517-4150 |
|
|
Passcode: 41315 # |
Update on Annual General and Special Meeting of Shareholders
On
Additional Information
The quarterly unaudited consolidated financial statements for the three and six months ended
Non-IFRS Measures
1 Adjusted EBITDA is a non-IFRS financial measure. This measure is not a recognized measure under IFRS, does not have a standardized meaning prescribed by IFRS and is therefore unlikely to be comparable to similar measures presented by other companies. The Company uses non-IFRS financial measures, namely, "Adjusted EBITDA", to provide investors with supplemental measures of its operating performance and to eliminate items that have less bearing on operating performance or operating conditions and thus highlight trends in its core business that may not otherwise be apparent when relying solely on IFRS financial measures. Specifically, the Company believes that the aforementioned non-IFRS financial measure, when viewed with the Company's results under IFRS and the accompanying reconciliations, provide useful information about the Company's business without regard to potential distortions. By eliminating potential differences in results of operations between periods caused by factors such as depreciation and amortization methods and acquisition, restructuring, impairment and other charges such as acquisition, listing and reorganization related expenses, integration expenses and corporate cost allocations, the Company believes that the non-IFRS financial measures included herein can provide a useful additional basis for comparing the current performance of the underlying operations being evaluated.
Below is the Company's definition of the non-IFRS measure used herein:
"Adjusted EBITDA" adjusts net loss by adding back financing costs, amortization, depreciation and impairment costs, income tax expense (recovery), stock-based compensation expense (recovery), loss (gain) on contingent receivables and assets held for sale, specific transaction-related expenses related to acquisition and reorganization related expenses, integration and operational restructuring costs and other non-recurring expenses. Operational restructuring costs are incurred as a direct or indirect result of acquisition activities.
See reconciliations in the tables attached to this press release.
ABOUT
Additional information can be found at www.dyedurham.com.
Forward-looking Statements
This press release may contain forward-looking information and forward-looking statements within the meaning of applicable securities laws, which reflects the Company's current expectations regarding future events, including statements with respect to the declaration and payment of dividends, the Company's intended go-forward dividend policy, and the Company's intention to release a full strategic plan. In some cases, but not necessarily in all cases, forward-looking statements can be identified by the use of forward looking terminology such as "plans", "targets", "expects" or "does not expect", "is expected", "an opportunity exists", "is positioned", "estimates", "intends", "assumes", "anticipates" or "does not anticipate" or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might", "will" or "will be taken", "occur" or "be achieved". In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances contain forward-looking statements.
Forward-looking statements are not historical facts, nor guarantees or assurances of future performance but instead represent management's current beliefs, expectations, estimates and projections regarding future events and operating performance. The forward-looking information is based on management's opinions, estimates and assumptions, including, but not limited to: the
While these opinions, estimates and assumptions are considered by
There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. No forward-looking statement is a guarantee of future results. Accordingly, you should not place undue reliance on forward-looking information, which speaks only as of the date made. The forward-looking information contained in this press release represents
Consolidated Results of Operations
|
|
|
Three months ended |
Six months ended |
||
|
|
|
|
2024 |
|
2024 |
|
|
|
2025 |
(Restated) |
2025 |
(Restated) |
|
|
|
$ |
$ |
$ |
$ |
|
|
|
|
|
|
|
|
Revenue |
|
107,024 |
115,746 |
215,326 |
232,137 |
|
|
|
|
|
|
|
|
Expenses |
|
|
|
|
|
|
Direct costs |
|
(8,607) |
(9,827) |
(18,453) |
(18,813) |
|
Technology and operations |
|
(28,368) |
(26,460) |
(58,663) |
(51,356) |
|
General and administrative |
|
(14,445) |
(10,584) |
(26,538) |
(21,165) |
|
Sales and marketing |
|
(5,252) |
(4,223) |
(10,885) |
(8,600) |
|
Stock-based (compensation) recovery (expense) |
|
(932) |
47,642 |
(3,698) |
42,451 |
|
Finance costs, net |
|
(27,339) |
(55,839) |
(73,224) |
(90,422) |
|
Amortization, depreciation and impairment |
|
(30,629) |
(41,415) |
(64,256) |
(81,758) |
|
Acquisition, restructuring and other costs |
|
(15,930) |
(40,162) |
(22,660) |
(43,970) |
|
Loss before income taxes |
|
(24,478) |
(25,122) |
(63,051) |
(41,496) |
|
Income tax recovery |
|
2,688 |
5,458 |
2,989 |
6,537 |
|
Net loss |
|
(21,790) |
(19,664) |
(60,062) |
(34,959) |
|
|
|
|
|
|
|
|
Net loss attributable to:
|
|
|
|
|
|
|
Non-controlling interests |
|
4 |
705 |
(250) |
479 |
|
Shareholders |
|
(21,794) |
(20,369) |
(59,812) |
(35,438) |
|
|
|
(21,790) |
(19,664) |
(60,062) |
(34,959) |
|
|
|
|
|
|
|
|
Net loss per common share |
|
|
|
|
|
|
Basic |
|
(0.32) |
(0.30) |
(0.89) |
(0.53) |
|
Diluted |
|
(0.32) |
(0.30) |
(0.89) |
(0.53) |
|
|
|
|
|
|
|
|
Weighted average number of shares outstanding Basic |
|
|
|
|
|
|
Basic |
|
67,171 |
66,975 |
67,171 |
66,945 |
|
Diluted |
|
67,171 |
66,975 |
67,171 |
66,945 |
|
Certain comparative figures for
the three and six months ended |
Adjusted EBITDA
|
|
Three months ended |
Six months ended |
||
|
|
|
2024 |
|
2024 |
|
|
2025 |
(Restated) |
2025 |
(Restated) |
|
|
$ |
$ |
$ |
$ |
|
|
|
|
|
|
|
Loss for the period |
(21,790) |
(19,664) |
(60,062) |
(34,959) |
|
Amortization, depreciation and impairment(1) |
30,629 |
41,415 |
64,256 |
81,758 |
|
Finance costs(2) |
27,339 |
55,839 |
73,224 |
90,422 |
|
Income tax recovery |
(2,688) |
(5,458) |
(2,989) |
(6,537) |
|
Stock-based compensation expense (recovery)(3) |
932 |
(47,642) |
3,698 |
(42,451) |
|
Acquisition, restructuring, and other costs(4) |
15,930 |
40,162 |
22,660 |
43,970 |
|
Adjusted EBITDA(5) |
50,352 |
64,652 |
100,787 |
132,203 |
|
Certain comparative figures for
the three and six months ended |
|
|
|
|
|
(1) |
Depreciation and amortization expense is primarily related to acquired and developed intangible assets, depreciation expense on property, equipment, and right-of-use assets. |
|
(2) |
Finance costs are primarily related to interest expenses incurred on borrowings, changes in fair value of convertible debt and derivatives, lease obligations, net of interest income. |
|
(3) |
Stock-based compensation represents expenditures recognized in connection with stock options issued to employees and directors and cash settled share appreciation rights issued to directors and other related costs. |
|
(4) |
Acquisition, restructuring, and other costs relates to professional fees and integration costs incurred in connection with acquisition, divestiture, listing, reorganization related expenses and changes in fair value of contingent consideration. Restructuring expenses mainly represent employee exit costs as a result of synergies created due to business combinations and organizational changes and are expected to be paid within the fiscal year. Other costs primarily relate to non-recurring costs, including severance, and legal, advisory and other professional fees associated with the change in the Board and the delayed filing of the financial statements. |
|
(5) |
Represents a non-IFRS measure. See "Non-IFRS Measures". |
Condensed Consolidated Interim Statements of Financial Positions (Unaudited)
(Expressed in thousands of Canadian dollars)
As at:
|
|
|
|
|
|
2025 |
2025 |
|
|
$ |
$ |
|
|
|
|
|
Assets |
|
|
|
Current assets: |
|
|
|
Cash and cash equivalents |
37,849 |
43,098 |
|
Trade and other receivables |
73,106 |
88,077 |
|
Prepaid expenses and other assets |
14,870 |
11,865 |
|
Restricted investments |
185,000 |
185,000 |
|
|
310,825 |
328,040 |
|
Assets held for sale |
6,577 |
— |
|
|
317,402 |
328,040 |
|
Non-current assets: |
|
|
|
Prepayment option |
178 |
20,947 |
|
Property and equipment, net |
7,310 |
8,111 |
|
Right-of-use assets, net |
12,772 |
13,872 |
|
Intangible assets, net |
624,325 |
676,599 |
|
|
1,100,935 |
1,100,171 |
|
Other assets |
2,697 |
3,776 |
|
Total assets |
2,065,619 |
2,151,516 |
|
|
|
|
|
Liabilities and equity |
|
|
|
Current liabilities: |
|
|
|
Accounts payable and accrued liabilities |
73,722 |
78,833 |
|
Customer advances |
20,432 |
24,888 |
|
Holdbacks and contingent considerations, current |
28,302 |
36,218 |
|
Lease liabilities, current |
5,734 |
5,153 |
|
Loans and borrowings, current |
18,233 |
18,285 |
|
Derivative liabilities, current |
3,678 |
— |
|
Convertible debentures |
316,639 |
335,433 |
|
|
466,740 |
498,810 |
|
Liabilities directly associated with assets held for sale |
2,254 |
— |
|
|
468,994 |
498,810 |
|
Non-current liabilities: |
|
|
|
Holdbacks and contingent considerations |
10,069 |
20,637 |
|
Lease liabilities |
10,618 |
12,452 |
|
Loans and borrowings |
1,249,341 |
1,233,158 |
|
Derivative liabilities |
10,129 |
29,268 |
|
Deferred tax liabilities |
92,139 |
99,641 |
|
Other liabilities |
2,423 |
2,226 |
|
Total liabilities |
1,843,713 |
1,896,192 |
|
|
|
|
|
Equity |
|
|
|
Capital stock |
824,165 |
824,113 |
|
Contributed surplus |
53,863 |
50,116 |
|
Accumulated other comprehensive income (loss) |
16,559 |
(6,286) |
|
Deficit |
(672,949) |
(613,137) |
|
Non-controlling interests |
268 |
518 |
|
|
221,906 |
255,324 |
|
Total liabilities and equity |
2,065,619 |
2,151,516 |
|
|
|
|
|
Q3 2025 |
|
|
|
Quarterly Results |
Q2 2026 |
Q1 2026 |
Q4 2025 |
(Restated) |
|
|
|
(In thousands of Canadian dollars, except per share data) |
$ |
$ |
$ |
$ |
|
|
|
|
|
|
|
|
|
|
|
Revenue |
107,024 |
108,302 |
105,173 |
103,420 |
|
|
|
Net loss(1) |
(21,790) |
(38,272) |
(29,552) |
(23,449) |
|
|
|
Adjusted EBITDA(2) |
50,352 |
50,435 |
47,744 |
52,862 |
|
|
|
|
|
|
|
|
|
|
|
Net loss per common share |
(0.32) |
(0.57) |
(0.44) |
(0.35) |
|
|
|
Net loss per diluted share |
(0.32) |
(0.57) |
(0.44) |
(0.35) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Q2 2025 |
Q1 2025 |
Q4 2024 |
Q3 2024 |
|
|
|
Quarterly Results |
(Restated) |
(Restated) |
(Restated) |
(Restated) |
|
|
|
(In thousands of Canadian dollars, except per share data) |
$ |
$ |
$ |
$ |
|
|
|
|
|
|
|
|
|
|
|
Revenue |
115,746 |
116,391 |
117,520 |
103,452 |
|
|
|
Net loss(1) |
(19,664) |
(15,295) |
(97,425) |
(27,118) |
|
|
|
Adjusted EBITDA(2) |
64,652 |
67,551 |
65,976 |
56,454 |
|
|
|
|
|
|
|
|
|
|
|
Net loss per common share |
(0.30) |
(0.23) |
(1.63) |
(0.43) |
|
|
|
Net loss per diluted share |
(0.30) |
(0.23) |
(1.63) |
(0.43) |
|
|
|
Certain comparative figures for 2024 and the first, second and third quarters of 2025 have been restated.
See "Restatement of Prior Period Comparative Information" in Note 2 of the Condensed Consolidated Interim Financial Statements for the three and six months ended |
|
|
|
|
|
(1) Includes income tax expense (recovery). |
|
(2) Represents a non-IFRS measure. See "Non-IFRS Measures". |
SOURCE